Evidence map›Paper›PMID 30042328›Full record

ArticleInternational journal of molecular sciences2018

Bornyl

Tzu-Yen Yang, Mei-Li Wu, Chi-I Chang, Chih-I Liu, Te-Chih Cheng, Yu-Jen Wu

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.8field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Matrix Metalloproteinase Inhibition in Melanoma.Experimental dermatology · 2026
    Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Epithelial-Mesenchymal Transition (EMT).International journal of molecular sciences · 2023
    Article
  9. Review
  10. Article
  11. Stellettin B Isolated fromInternational journal of cell biology · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Tzu-Yen YangDepartment of Food Science, National Pingtung University of Science and Technology, Pingtung 91201, Taiwan. gini0307@yahoo.com.tw.
Mei-Li WuDepartment of Food Science, National Pingtung University of Science and Technology, Pingtung 91201, Taiwan. mlwu@mail.npust.edu.tw.
Chi-I ChangDepartment of Biological Science and Technology, National Pingtung University of Science and Technology, Pingtung 91201, Taiwan. changchii@mail.npust.edu.tw.
Chih-I LiuDepartment of Nursing, Mei-ho University, Pingtung 91202, Taiwan. x00002177@meiho.edu.tw.
Te-Chih ChengDepartment of Nursing, Mei-ho University, Pingtung 91202, Taiwan. x00003077@meiho.edu.tw.
Yu-Jen WuDepartment of Biological Technology, Meiho University, Pingtung 91202, Taiwan. x00002180@meiho.edu.tw.
Meiho University · TWNational Pingtung University of Science and Technology · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bornyl

Indexed as

Antineoplastic AgentsCamphanesCell Line, TumorCell MovementClass II Phosphatidylinositol 3-KinasesCoumaric AcidsDose-Response Relationship, DrugEpithelial-Mesenchymal TransitionFocal Adhesion Kinase 1HumansHydroxidesMAP Kinase Signaling SystemMelanomaNeoplasm InvasivenessNeoplasm MetastasisPhytochemicalsAntineoplastic AgentsCamphanesClass II Phosphatidylinositol 3-KinasesCoumaric AcidsFocal Adhesion Kinase 1hydroxide ionHydroxidesMTOR protein, humanPhytochemicalsPTK2 protein, humanTOR Serine-Threonine Kinasesbornyl cis-4-hydroxycinnamatecell invasioncell migrationepithelial to mesenchymal transitionmelanomaPiper betle stems

Identifiers

PMID30042328
PMCPMC6121392
OpenAlexW2884058624

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.